Related Experiment Video
Updated: Apr 5, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Tuberculosis (HIV-negative people): improving adherence
Liliya Eugenevna Ziganshina1, Michael Eisenhut
1Kazan Federal University, Kazan, Russia.
This systematic overview evaluated directly observed treatment (DOT) versus self-administered treatment (SAT) for tuberculosis (TB). It categorized the efficacy of 13 interventions for TB treatment effectiveness and safety.
Area of Science:
- Public Health
- Infectious Diseases
- Clinical Medicine
Background:
- Tuberculosis (TB) affects approximately one-third of the global population.
- In 2013, TB caused 9.0 million new cases and 1.5 million deaths worldwide.
- Research is crucial to optimize TB treatment strategies.
Purpose of the Study:
- To systematically review the effectiveness and safety of directly observed treatment (DOT) compared to self-administered treatment (SAT) for tuberculosis patients without HIV.
- To assess the impact of support mechanisms for DOT in tuberculosis management.
- To answer key clinical questions regarding TB treatment efficacy.
Main Methods:
- A systematic overview was conducted, searching major databases including Medline, Embase, and The Cochrane Library up to June 2014.
- 189 studies were initially retrieved, with 104 records screened after deduplication.
- 18 full publications were evaluated, including three new systematic reviews and one RCT, with a GRADE evaluation for 12 PICO combinations.
Main Results:
- The overview identified and evaluated evidence for 13 interventions related to TB treatment.
- Data focused on the effectiveness and safety of DOT and its support mechanisms.
- GRADE methodology was applied to assess the quality of evidence.
Conclusions:
- The study categorized the efficacy of 13 interventions for tuberculosis treatment.
- Findings provide insights into the effectiveness and safety of directly observed treatment and its support mechanisms.
- This systematic overview contributes to understanding optimal TB care strategies.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Sexually Transmitted Infections